Presentation on theme: "Company Radiant Energy Vacuum (“REV”) Dehydration Technology"— Presentation transcript:
1 REV Dehydration: Commercial Drying Technology for Foods and Food Ingredients
2 Company Radiant Energy Vacuum (“REV”) Dehydration Technology Vancouver-based industrial technology company, UBC spin-offProprietary method of drying food, bulk liquids, biological and pharmaceutical materials
3 Method Radiant Energy Vacuum (“REV”) Microwave energy under vacuum enables high-speed, low temperature drying above or below freezing pointPreserve nutritional value, bioactivity, flavor, color, texture better than high temperature methods such as spray or air dryingTarget to replace conventional drying for sensitive materials and enable new dry products
4 REV Technology Technology Overview REV technology applies microwave energy under vacuum for high-speed drying at low temperaturesKey discoveries:1. Methods of distributing a microwave field to avoid plasma discharge in vacuum.2. Means of achieving reliable, homogeneous dehydration across a large load.3. Continuous processing.
5 REV TechnologyTargeted AdvantagesFasterDry in minutes or hours versus days, for reduced capital costsContinuousReduces labour & energy, easily automatedBetterMost economical way to dry temperature sensitive products and retain quality, such as biological activity, nutrients, colour, solubility, etc.
6 PuffingSteam & air bubbles inside material can expand & create puffed structure.If material is dehydrated until rigid, expansion will be retainedExample: flour & water dough balls.
12 nutraREV™ Technology Production of biological powders Kale Carrot BlueberryCranberry
13 nutraREV™ TechnologynutraREV™ dried products show similar or better nutrition retention than freeze dried:ProductFresh frozenAir DriednutraREV™Freeze DryVitamin A (μg)Carrot1500115012801380Vitamin C (μg)450150400Anthocyanins (mg)Blueberry5.32.05.05.2Phenolics (mg)35.521.533.524.5Antioxidants (TBARS)322023Data is per grams of solids.* Sources: Durance et al US Patent 6,312,745: Lin et al Food Res. International 31:111.1313
18 powderREVTM for Rapid, Bulk Powder Freeze Drying | TSX-V: ENW | FSE: E4U
19 powderREV™ Processing biological materials in bulk Converts frozen liquids, purees, or solids into dried powderCollaboration project with Danisco AS, dominant global supplier of freeze dried food cultures & probioticsSuccessful prototype test completed March 2010Delivery target for continuous pilot machine in Q2 2011
21 quantaREV™ New REV design for continuous large scale vacuum drying Modular design and belt conveyor allows very large scale processing of liquids, pastes, or solidsProprietary microwave design minimizes costs and prevents arcingExtends REV potential into larger volume product areas:Fruits & vegetablesProteins (soy, canola, milk, eggs, plasma)Meat pureesEnzymes (detergents, bio fuels, rubber, beer, spirits)EnWave to establish exclusive collaborations with market leaders to broaden market acceptance of quantaREV™
30 High-speed, low temperature drying of purees; dried and ground.
31 bioREVTM & freezeREVTM for Pharmaceutical Dehydration | TSX-V: ENW | FSE: E4U
32 16 REV Patents Strong Intellectual Property Base patents (8) issued to University of BC, EnWave has exclusive global rights to their use. Company has been filing its own patents since 2008Includes two issued Canadian patent for REV drying of gels, pastes and foams containing bioactive ingredients, also filed in US, EU, Australia, China, HK, and India, etc.MIVAP US PatentsnutraREV™ and powderREV™ equipment patents filed by EnWave and pending in major jurisdictions around the world
33 Commercial Progression Technology Development Targets as of October 2010REV TechnologyPatents filed , issued or pendingConceptual prototypestagePilot development stageCommercial development stage (1)Multi-national collaboration partnersnutraREV™Nestlé & BimbopowderREV™9 to 12 months (2)DaniscoquantaREV™12 to 18monthsGrimmwayMIVAP™N/ACommercial machine with dried capacity of up to 100 Kilo per hour sold to CAL-SANExpected time required to complete pilot machine testing, Danisco licence agreement and secure first commercial machine order for delivery in first half of 2012FDA GMP regulatory approvals required for therapeutic pharmaceutical applications
34 Contact Details Contact Us Tim Durance Chairman & Co-CEO John McNicol Phone: (604) Cell: (604)John McNicolPresident & Co-CEOPhone: (604)